These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

547 related items for PubMed ID: 19017445

  • 21. Bacille Calmette Guérin vaccination in pre-term infants.
    Sedaghatian MR, Hashem F, Moshaddeque Hossain M.
    Int J Tuberc Lung Dis; 1998 Aug; 2(8):679-82. PubMed ID: 9712284
    [Abstract] [Full Text] [Related]

  • 22. Disseminated Bacillus Calmette-Guerin infection after BCG vaccination.
    Rezai MS, Khotaei G, Mamishi S, Kheirkhah M, Parvaneh N.
    J Trop Pediatr; 2008 Dec; 54(6):413-6. PubMed ID: 18593737
    [Abstract] [Full Text] [Related]

  • 23. Bacille Calmette-Guerin disease following Bacille Calmette-Guerin vaccination of an HIV-infected health-care worker.
    Vera JH, Hill SC, Rubinstein L.
    Int J STD AIDS; 2012 Jul; 23(7):e1-2. PubMed ID: 22844017
    [Abstract] [Full Text] [Related]

  • 24. Comment on Hesseling, et al. "The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children" [Vaccine 25 (2006) 14-18].
    Taştan Y.
    Vaccine; 2007 Jun 06; 25(23):4513. PubMed ID: 17434241
    [No Abstract] [Full Text] [Related]

  • 25. The immune response to BCG vaccination of newborns.
    Hanekom WA.
    Ann N Y Acad Sci; 2005 Dec 06; 1062():69-78. PubMed ID: 16461790
    [Abstract] [Full Text] [Related]

  • 26. Bacille Calmette-Guérin vaccine-related disease in HIV-infected children: a systematic review.
    Azzopardi P, Bennett CM, Graham SM, Duke T.
    Int J Tuberc Lung Dis; 2009 Nov 06; 13(11):1331-44. PubMed ID: 19861003
    [Abstract] [Full Text] [Related]

  • 27. Use of BCG in high prevalence areas for HIV.
    Felten MK, Leichsenring M.
    Trop Med Parasitol; 1995 Jun 06; 46(2):69-71. PubMed ID: 8525287
    [Abstract] [Full Text] [Related]

  • 28. Disseminated bacille Calmette-Guérin disease in HIV-infected South African infants.
    Hesseling AC, Johnson LF, Jaspan H, Cotton MF, Whitelaw A, Schaaf HS, Fine PE, Eley BS, Marais BJ, Nuttall J, Beyers N, Godfrey-Faussett P.
    Bull World Health Organ; 2009 Jul 06; 87(7):505-11. PubMed ID: 19649364
    [Abstract] [Full Text] [Related]

  • 29. Adverse effects of bacille Calmette-Guerin vaccination in HIV-positive infants.
    Hussey G, Hawkridge T, Eley B, Nuttall J, Kibel M, Geiter L, Barker L, Behr M, Demers AM.
    Clin Infect Dis; 2004 May 01; 38(9):1333-4; author reply 1334-5. PubMed ID: 15127353
    [No Abstract] [Full Text] [Related]

  • 30. Adverse reactions to the Bacillus Calmette-Guerin vaccine in HIV-positive infants.
    Alexander A, Rode H.
    J Pediatr Surg; 2007 Mar 01; 42(3):549-52. PubMed ID: 17336197
    [Abstract] [Full Text] [Related]

  • 31. A cost-effectiveness analysis of universal versus selective immunization with Mycobacterium bovis bacille Calmette-Guérin in Finland.
    Hersh AL, Tala-Heikkilä M, Tala E, Tosteson AN, Fordham von Reyn C.
    Int J Tuberc Lung Dis; 2003 Jan 01; 7(1):22-9. PubMed ID: 12701831
    [Abstract] [Full Text] [Related]

  • 32. The BCG vaccine: information and recommendations for use in Australia.
    National Tuberculosis Advisory Committee.
    Commun Dis Intell Q Rep; 2006 Jan 01; 30(1):109-15. PubMed ID: 16637239
    [Abstract] [Full Text] [Related]

  • 33. [BCG vaccination in the world].
    Toida I.
    Kekkaku; 2000 Jan 01; 75(1):1-7. PubMed ID: 10689812
    [Abstract] [Full Text] [Related]

  • 34. Immune reconstitution inflammatory syndrome (IRIS) due to Bacille Calmette Guerin (BCG) in an HIV-positive child.
    Kroidl A, Huck K, Weinspach S, Gudowius S, Mackenzie CR, Oette M, Häussinger D, Niehues T.
    Scand J Infect Dis; 2006 Jan 01; 38(8):716-8. PubMed ID: 16857624
    [Abstract] [Full Text] [Related]

  • 35. BCG vaccine: WHO position paper, February 2018 - Recommendations.
    World Health Organization.
    Vaccine; 2018 Jun 07; 36(24):3408-3410. PubMed ID: 29609965
    [Abstract] [Full Text] [Related]

  • 36. Concerns on Bacille Calmette-Guerin vaccination in infants born to mothers with hepatitis B virus infection.
    Hu Y, Zhou YH.
    Vaccine; 2009 Mar 23; 27(14):1987-8. PubMed ID: 19428825
    [No Abstract] [Full Text] [Related]

  • 37. The effect of Bacille Calmette-Guérin vaccine on tuberculin reactivity in indigenous children from communities with high prevalence of tuberculosis.
    Araujo Z, de Waard JH, de Larrea CF, Borges R, Convit J.
    Vaccine; 2008 Oct 16; 26(44):5575-81. PubMed ID: 18723065
    [Abstract] [Full Text] [Related]

  • 38. To BCG or not to BCG? Preventing travel-associated tuberculosis in children.
    Ritz N, Connell TG, Curtis N.
    Vaccine; 2008 Nov 05; 26(47):5905-10. PubMed ID: 18804139
    [Abstract] [Full Text] [Related]

  • 39. A review of rotavirus infection in and vaccination of human immunodeficiency virus-infected children.
    Steele AD, Cunliffe N, Tumbo J, Madhi SA, De Vos B, Bouckenooghe A.
    J Infect Dis; 2009 Nov 01; 200 Suppl 1():S57-62. PubMed ID: 19817615
    [Abstract] [Full Text] [Related]

  • 40. Bacillus Calmette-Guérin infection after vaccination of human immunodeficiency virus-infected children.
    Besnard M, Sauvion S, Offredo C, Gaudelus J, Gaillard JL, Veber F, Blanche S.
    Pediatr Infect Dis J; 1993 Dec 01; 12(12):993-7. PubMed ID: 8108227
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.